Lawfare's Quinta Jurecic on what's next for the January 6th Committee and the steps Congress can take to safeguard American democracy.
Guest Host: Katty Kay
A new drug has been approved by the F.D.A. to treat fibromyalgia, a condition characterized by chronic and widespread pain. We’ll talk about some of the ongoing questions related to its diagnosis and treatment.
- Frances Bremer Spokesperson, National Fibromyalgia Association
- Dr. Nortin Hadler Professor of Medicine and Microbiology/Immunology University of North Carolina at Chapel Hill Attending Rheumatologist, UNC Hospitals
- Alex Berenson Reporter, New York Times
- Dr. Patrick Wood Researcher and clinician specializing in fibromyalgia, chief medical officer of Angler Biomedical Technologies
Most Recent Shows
Susan Glasser and Peter Baker are veteran political journalists who closely covered the presidency of Donald Trump, he as the New York Times chief White House correspondent, she as a…
For months it looked like Russia was waging – and winning -- a battle of attrition. But last week Ukrainian forces made dramatic gains on the battlefield, retaking vast areas…
From McCarthyism to January Sixth, best-selling author David Corn says the G.O.P has a long history of using paranoia, grievance, and tribalism for political gain. His new book is "American Psychosis."